Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.02 | N/A |
| PEG Ratio (TTM) | -4.96 | N/A |
| P/S Ratio (TTM) | 1.88 | N/A |
| P/B Ratio (TTM) | 0.78 | N/A |
| P/FCF Ratio (TTM) | 10.14 | N/A |
| Price to 5YR AVG Earnings Ratio | 4.90 | N/A |
| Price to 5YR AVG FCF Ratio | 4.03 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.59% | N/A |
| ROE (TTM) | 5.35% | N/A |
| Net Profit Margin (TTM) | 12.70% | N/A |
| ROIC 5YR AVG | 8.07% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.82% | 40.31% | 15.33% |
| Revenue | 4.49% | 2.86% | -14.09% |
| Net Income | 8.87% | 42.08% | 18.64% |
| Cash Flow | -10.76% | 617.38% | 381.01% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.36 | N/A |
| Quick Ratio (TTM) | 0.36 | N/A |
| D/E Ratio (TTM) | 0.56 | N/A |
| Interest Coverage (TTM) | 0.37 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 6.34 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.04% | N/A |